Transcriptional analysis of sodium valproate in a serotonergic cell line reveals gene regulation through both HDAC inhibition-dependent and independent mechanisms
- 1 March 2021
- journal article
- research article
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 21 (3) , 359-375
Abstract
Sodium valproate (VPA) is a histone deacetylase (HDAC) inhibitor, widely prescribed in the treatment of bipolar disorder, and yet the precise modes of therapeutic action for this drug are not fully understood. After exposure of the rat serotonergic cell line RN46A to VPA, RNA-sequencing (RNA-Seq) analysis showed widespread changes in gene expression. Analysis by four bioinformatic pipelines revealed as many as 230 genes were significantly upregulated and 72 genes were significantly downregulated. A subset of 23 differentially expressed genes was selected for validation using the nCounter® platform, and of these we obtained robust validation for ADAM23, LSP1, MAOB, MMP13, PAK3, SERPINB2, SNAP91, WNT6, and ZCCHC12. We investigated the effect of lithium on this subset and found four genes, CDKN1C, LSP1, SERPINB2, and WNT6 co-regulated by lithium and VPA. We also explored the effects of other HDAC inhibitors and the VPA analogue valpromide on the subset of 23 selected genes. Expression of eight of these genes, CDKN1C, MAOB, MMP13, NGFR, SHANK3, VGF, WNT6 and ZCCHC12, was modified by HDAC inhibition, whereas others did not appear to respond to several HDAC inhibitors tested. These results suggest VPA may regulate genes through both HDAC-dependent and independent mechanisms. Understanding the broader gene regulatory effects of VPA in this serotonergic cell model should provide insights into how this drug works and whether other HDAC inhibitor compounds may have similar gene regulatory effects, as well as highlighting molecular processes that may underlie regulation of mood.Keywords
All Related Versions
This publication has 115 references indexed in Scilit:
- Allen Brain Atlas: an integrated spatio-temporal portal for exploring the central nervous systemNucleic Acids Research, 2012
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Extracellular matrix abnormalities in schizophreniaNeuropharmacology, 2012
- Interaction networks of lithium and valproate molecular targets reveal a striking enrichment of apoptosis functional clusters and neurotrophin signalingThe Pharmacogenomics Journal, 2011
- Molecular pharmacology in a simple model system: Implicating MAP kinase and phosphoinositide signalling in bipolar disorderSeminars in Cell & Developmental Biology, 2011
- Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiationNature Biotechnology, 2010
- Valproic acid in pregnancy: How much are we endangering the embryo and fetus?Reproductive Toxicology, 2009
- Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patientsMolecular Psychiatry, 2009
- Chronic Administration of Mood Stabilizers Upregulates BDNF and Bcl-2 Expression Levels in Rat Frontal CortexNeurochemical Research, 2008
- Mania-like behavior induced by disruption of CLOCKProceedings of the National Academy of Sciences, 2007